Clinical Trial Update: Epanova® for Lowering Very High Triglycerides [Phase 2, Phase 3]

View source ↗

Summary

Epanova was studied in phase 2 and phase 3 trials to lower very high triglycerides in patients with hypertriglyceridemia. The study is completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Hypertriglyceridemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-09-06